← Back to patent-cliff list
CAS 1000783-47-0
21H-9,12-Imino-2,22-metheno-7,4:14,17-dinitrilo-1H-oxepino[4,5-b]azacyclononadecine-16-propanoic acid, 10-ethenyl-5-ethyl-15,16,18,19-tetrahydro-6,11,15,23-tetramethyl-19,21-dioxo-, (15S,16S)-
Codes: TALAS-004
Application context (from source-drug indications)
Lung cancerTalaporfin Sodium脑癌Talaporfin Sodium脉络膜新生血管化Talaporfin Sodium年龄相关性黄斑变性Talaporfin SodiumPort-wine stainTalaporfin SodiumBenign prostatic hyperplasiaTalaporfin Sodium
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Talaporfin Sodium | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
TALAS-001→21H-9,12-Imino-2,22-metheno-7,4:14,17-dinitrilo-1H-oxepino[4,5-b]azacyclononadecine-16-propanoic acid, 10-ethenyl-5-ethyl-15,16,18,19-tetrahydro-6,11,15,23-tetramethyl-19,21-dioxo-, (15S,16S)-→(S)-2-aminosuccinic acid
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.